Bryophyllum vs. Nifedipine

• Status: Unknown status
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

In a prospective, randomised study the efficacy and tolerability of bryophyllum p. (p.o) vs. nifedipine (p.o) will be proofed in a defined group of pregnant women with threatened preterm labour.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Weleda AG
• Treatments: Nifedipine

Criteria

Inclusion Criteria:

• Female

Exclusion Criteria:

• Bishop Score > 5